{
  "company": {
    "name": "Enara Bio",
    "website": "https://enarabio.com/",
    "record": "https://startuphistory.org/c/enarabio.com"
  },
  "status": null,
  "history_since": "2020-08-12T20:12:47.000Z",
  "baseline": {
    "snapshot_id": "a09a10c65a813663b87f5a9597c45443dc46854794a3ac7c6178538ba0504af2",
    "observed_at": "2020-08-12T20:12:47.000Z",
    "headline": "Illuminating the immune interface to develop new cancer therapies",
    "description": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
    "evidence": "https://web.archive.org/web/20200812201247/https://enarabio.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T16:53:53.439Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2021-08-03T04:39:16.000Z",
      "variants": [
        {
          "headline": "Illuminating the immune interface to develop new cancer therapies",
          "subhead": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
          "observed_at": "2020-08-12T20:12:47.000Z",
          "evidence": "https://web.archive.org/web/20200812201247/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Illuminating the immune interface to develop new cancer therapies",
          "subhead": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
          "observed_at": "2021-01-12T17:55:13.000Z",
          "evidence": "https://web.archive.org/web/20210112175513/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Illuminating the immune interface to develop new cancer therapies",
          "subhead": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
          "observed_at": "2021-08-03T04:39:16.000Z",
          "evidence": "https://web.archive.org/web/20210803043916/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Illuminating the immune interface to develop new cancer therapies",
      "subhead": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
      "from": "2020-08-12T20:12:47.000Z",
      "to": "2021-08-03T04:39:16.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20210803043916/https://enarabio.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-08-12T20:12:47.000Z",
          "to": "2021-08-03T04:39:16.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2026-11-06T16:53:53.439Z",
      "variants": [
        {
          "headline": "Advancing cancer immunotherapy by targeting the unconventional",
          "subhead": "Enara Bio is exploring the hidden depths of cancer biology to discover and characterize novel immunotherapy targets, such as Dark Antigens derived from the genomic dark matter or antigens presented by",
          "observed_at": "2022-07-01T17:18:26.000Z",
          "evidence": "https://web.archive.org/web/20220701171826/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2023-02-03T00:53:08.000Z",
          "evidence": "https://web.archive.org/web/20230203005308/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2023-07-07T21:30:11.000Z",
          "evidence": "https://web.archive.org/web/20230707213011/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2024-01-03T19:34:47.000Z",
          "evidence": "https://web.archive.org/web/20240103193447/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2025-01-22T00:52:21.000Z",
          "evidence": "https://web.archive.org/web/20250122005221/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2025-07-09T16:06:44.000Z",
          "evidence": "https://web.archive.org/web/20250709160644/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-01-08T22:12:20.000Z",
          "evidence": "https://web.archive.org/web/20260108221220/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-04-21T01:46:33.000Z",
          "evidence": "https://web.archive.org/web/20260421014633/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-05-18T15:48:08.000Z",
          "evidence": "https://web.archive.org/web/20260518154808/https://enarabio.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Unleashing unconventional antigens for cancer immunotherapy",
          "subhead": null,
          "observed_at": "2026-11-06T16:53:53.439Z",
          "evidence": "https://enarabio.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Unleashing unconventional antigens for cancer immunotherapy",
      "subhead": null,
      "from": "2022-07-01T17:18:26.000Z",
      "to": "2026-11-06T16:53:53.439Z",
      "captures": 10,
      "evidence": "https://enarabio.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2022-07-01T17:18:26.000Z",
          "to": "2026-11-06T16:53:53.439Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-9057998b92654164a43b9ba42e18c9c5b8a84ebdf790796291def15cc54072a4:11de006b8b3518da9434b8dda46284b8d0e6314153ccf07b7555cbf89cd1846e:headline:acf1e82fa4a401cc",
      "before_evidence": "https://web.archive.org/web/20210803043916/https://enarabio.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "headline",
      "label": "Headline",
      "summary": "Changed its homepage headline from “Illuminating the immune interface to develop new cancer therapies” to “Advancing cancer immunotherapy by targeting the unconventional”.",
      "between": {
        "from": "2021-08-03T04:39:16.000Z",
        "to": "2022-07-01T17:18:26.000Z"
      },
      "evidence": "https://web.archive.org/web/20220701171826/https://enarabio.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": null
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Enara Bio” company record, https://startuphistory.org/c/enarabio.com"
}